The MIT-Takeda program will fuel the development and application of artificial intelligence capabilities to benefit human health and drug development.

A collaboration between MIT’s School of Engineering and Takeda Pharmaceutical Company Limited, and centered within the Abdul Latif Jameel Clinic for Machine Learning in Health, the MIT-Takeda Program will leverage the combined expertise of both organizations.

The MIT-Takeda Program will support MIT faculty, students, researchers, and staff across the Institute who are working at the intersection of AI and human health, ensuring that they can devote their energies to expanding the limits of knowledge and imagination. The new program will coalesce disparate disciplines, merge theory and practical implementation, combine algorithm and hardware innovations, and create multidimensional collaborations between academia and industry.